Alirocumab efficacy and safety by body mass index: Pooled analysis from 10 Phase 3 ODYSSEY trials. (August 2018) - Tinahones, F.; Laufs, U.; Cariou, B.; Yang, J.; Louie, M.J.; Thompson, D.; Leiter, L.A.